ADVFN
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Bio Path Holdings Inc

Bio Path Holdings Inc (BPTH)

0.1376
0.00
(0.00%)
0.00
0.00
(0.00%)

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

BPTH News

Official News Only

BPTH Discussion

View Posts
Here Today Here Today 5 months ago
Waaaaaaaay oversold in my opinion.
πŸ‘οΈ0
Renee Renee 5 months ago
BPTH delisted from the Nasdaq to the OTC. ***pps dropped 67% from .64 to .21 on 6.2 million volume.

https://otce.finra.org/otce/dailyList?viewType=Additions
πŸ‘οΈ0
glenn1919 glenn1919 5 months ago
BPTH.........................................................a/h
πŸ‘οΈ0
tw0122 tw0122 6 months ago
2m floater best dip grab some $1.20s
πŸ‘οΈ0
glenn1919 glenn1919 6 months ago
BPTH......................https://stockcharts.com/h-sc/ui?s=BPTH&p=W&b=5&g=0&id=p86431144783





...................thx..........................................
πŸ‘οΈ0
tw0122 tw0122 6 months ago
Was at $5 last week but $1.40 + 40% looks good now
πŸ‘οΈ0
TheFinalCD TheFinalCD 7 months ago
wise alert already down to 3.16 $BPTH 12/19/2024, 8:26:04 AMVote approved for warrants on Dec 12https://t.co/i1Mf5Hj2kc
HC Wainwright
MAKING HUGE $$$ AGAIN pic.twitter.com/aqQCm5Lyho— THE FINAL COUNTDOWN (@THIS_TIME_X) December 19, 2024
πŸ‘οΈ0
tw0122 tw0122 7 months ago
$4.05 +500% take those profits $$$
πŸ‘οΈ0
tw0122 tw0122 7 months ago
BPTH $3.69 + 453% obesity diabetes 
πŸ‘οΈ0
Here Today Here Today 7 months ago




πŸ‘οΈ0
Here Today Here Today 7 months ago


πŸ‘οΈ0
tw0122 tw0122 7 months ago
Still hot $2.88 
πŸ‘οΈ0
glenn1919 glenn1919 7 months ago
bpth...https://stockcharts.com/h-sc/ui?s=bpth&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
oleskool oleskool 8 months ago
this has to shake
πŸ‘οΈ0
glenn1919 glenn1919 9 months ago
bpth..............................https://stockcharts.com/h-sc/ui?s=BPTH&p=W&b=5&g=0&id=p86431144783
👍 1
tw0122 tw0122 9 months ago
Resistance 1.31- 1.51 time to exit trade seems logical zone to cash $$$$$$
πŸ‘οΈ0
Awl416 Awl416 9 months ago
Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
BPTH new 52+week low
πŸ‘οΈ0
saigai saigai 10 months ago
waiting avg 1.26
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
BPTH new 52=low
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
BPTH new 52+week low
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
BPTH new 52+week low
πŸ‘οΈ0
Here Today Here Today 11 months ago
I for one cannot understand how this stock price gets whacked every single time they PR good news.
πŸ‘οΈ0
saigai saigai 11 months ago
a train wreck..geez
πŸ‘οΈ0
Awl416 Awl416 11 months ago
Night night
πŸ‘οΈ0
glenn1919 glenn1919 11 months ago
BPTH...................................https://stockcharts.com/h-sc/ui?s=BPTH&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Monksdream Monksdream 11 months ago
Flushed
πŸ‘οΈ0
Awl416 Awl416 11 months ago
Ouch
πŸ‘οΈ0
Awl416 Awl416 11 months ago
Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid Tumors
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
BPTH new 52 week low
πŸ‘οΈ0
USAFpatriot USAFpatriot 1 year ago
The low float, today’s news and myeloid leukemia news should at least stabilize the stock if nothing else. Leukemia PR should have moved it more IMO.
πŸ‘οΈ0
Here Today Here Today 1 year ago
And the news really hasn’t started to make its rounds yet on wire notices. Will be interesting to see what the market feels about these pretty impressive results.
πŸ‘οΈ0
Here Today Here Today 1 year ago
Finally some good news reported today.
πŸ‘οΈ0
Here Today Here Today 1 year ago
https://stonegateinc.reportablenews.com/pr/stonegate-capital-partners-updates-coverage-on-bio-path-holdings-inc-nasdaq-bpth-q1-24
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
BPTH: Indeed!! (Both the 'Low-Float' and 'Anything-Pharma' theories are now ancient history.)
πŸ‘οΈ0
Here Today Here Today 1 year ago
Crazy that this has traded so many shares and the PPS is still where it currently sits with an incredibly small float of less than 2 million shares….
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
BPTH: Only 1.56-mil. Float, which might help this too. (But not quite sure if "FLOATS", per se, are trending anymore.)
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
BPTH: Circa where I too grabbed it. (Just when ya think "Cancer" ain't trending anymore.)
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
FILLED SOME 3.34'S

MOONMAN ON THIS @ 3.50 & 3.30
πŸ‘οΈ0
saj saj 1 year ago
Boom
πŸ‘οΈ0
saj saj 1 year ago
BPTH: Bio-Path Holdings Has Been Granted Israeli Patent Number 269608 Titled "COMPOSITIONS COMPRISING P-ETHOXY NUCLEIC ACIDS FOR STAT3 INHIBITION FOR USE IN TREATING CANCER OR AUTOIMMUNE DISEASE"
BENZINGA 8:44 AM ET 5/3/2024
πŸ‘οΈ0
Awl416 Awl416 1 year ago
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
πŸ‘οΈ0
tw0122 tw0122 1 year ago
New hi 3.85 700k float
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
BPTH new 52 lo
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
BPTH under $5
πŸ‘οΈ0
Awl416 Awl416 1 year ago
Volatility
πŸ‘οΈ0
Renee Renee 1 year ago
BPTH: effective Feb. 23,2024 a one for 20 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php
πŸ‘οΈ0
INV4 INV4 2 years ago
Bio-Path Holdings to Host Virtual Key Opinion Leader Event to Discuss Prexigebersen and Advances in the Treatment Landscape for Acute Myeloid Leukemia

October 24, 2023

Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced it will host a virtual key opinion leader event to highlight the prexigebersen program and discuss advances in the treatment landscape for acute myeloid leukemia (AML). The conference call will be held on Monday, October 30, 2023 at 9:00 a.m. ET.
The event will be hosted by Peter Nielsen, Chief Executive Officer of Bio-Path, and will feature presentations and discussion with:

Jorge Cortes, M.D., Director, Georgia Cancer Center, Augusta University
Maro Ohanian, D.O., Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center

To access the live conference call, please call (833) 630-1956 (domestic) or (412) 317-1837 (international) at least five minutes prior to the start time. A live audio webcast of the call will also be available on the Presentations section of the Company’s website, www.biopathholdings.com. An archived webcast will be available on the Bio-Path website approximately two hours after the event.

About Bio-Path Holdings, Inc.
Bio-Path is a biotechnology company developing DNAbilize®, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous transfusion. Bio-Path’s lead product candidate, prexigebersen (BP1001, targeting the Grb2 protein), is in a Phase 2 study for blood cancers, and BP1001-A, a drug product modification of prexigebersen, is in a Phase 1 study for solid tumors. The Company’s second product, BP1002, which targets the Bcl-2 protein, is being evaluated for the treatment of blood cancers and solid tumors, including lymphoma and acute myeloid leukemia. In addition, an IND application is expected to be filed for BP1003, a novel liposome-incorporated STAT3 antisense oligodeoxynucleotide developed by Bio-Path as a specific inhibitor of STAT3.

For more information, please visit the Company's website at http://www.biopathholdings.com.

Contact Information:

Investors

Will O’Connor
Stern Investor Relations
212-362-1200
will@sternir.com

Doug Morris
Investor Relations
Bio-Path Holdings, Inc.
832-742-1369

https://ih.advfn.com/stock-market/NASDAQ/bio-path-BPTH/stock-news/92348612/bio-path-holdings-to-host-virtual-key-opinion-lead

$BPTH
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock